Viewing Study NCT00892203


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2025-12-29 @ 5:39 AM
Study NCT ID: NCT00892203
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2009-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of BGG492 in the Treatment of Migraine
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module